2014
DOI: 10.3892/or.2014.3366
|View full text |Cite
|
Sign up to set email alerts
|

Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells

Abstract: Bradykinin (BK) has been reported to be involved in the progression of many types of cancer. In the present study, we investigated a possible role of BK in colorectal cancer cell invasion and migration. Invasion and migration assays showed that BK treatment promoted the invasion and migration of colorectal cancer cells. Further experiments showed that BK treatment stimulated ERK1/2 activation and IL-6 production. Two bradykinin receptors, bradykinin B1 receptor (B1R) and bradykinin B2 receptor (B2R), were sign… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
23
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 35 publications
(31 citation statements)
references
References 32 publications
(33 reference statements)
8
23
0
Order By: Relevance
“…29,47,48 In the current study, we demonstrated that nicotine stimulated IL-6 production in endothelial EA.hy926 cells and, in turn, enhanced cell invasiveness. 29,47,48 In the current study, we demonstrated that nicotine stimulated IL-6 production in endothelial EA.hy926 cells and, in turn, enhanced cell invasiveness.…”
Section: Discussionsupporting
confidence: 59%
“…29,47,48 In the current study, we demonstrated that nicotine stimulated IL-6 production in endothelial EA.hy926 cells and, in turn, enhanced cell invasiveness. 29,47,48 In the current study, we demonstrated that nicotine stimulated IL-6 production in endothelial EA.hy926 cells and, in turn, enhanced cell invasiveness.…”
Section: Discussionsupporting
confidence: 59%
“…Previous studies showed the effects of bradykinin on stimulating cancer cells. For example, bradykinin can trigger proliferation, migration, and invasion of gastric cancer cells and cervical cancer cells via activation of the ERK and signal transducer and activator of transcription (STAT)-3 signaling pathways [35,36]. In hepatocellular carcinoma cells, bradykinin can trigger tumor metastasis [37].…”
Section: Discussionmentioning
confidence: 99%
“…The active peptide Bradykinin is released from HMW‐kininogen by Kallikrein cleavage and as mediator of inflammation shows a variety of physiological effects, such as: influence in smooth muscle contraction, induction of hypotension, and regulation of vascular permeability. It is known the role of Bradykinin in colon carcinogenesis (Graness et al, ; Wang et al, ). Controversially, we found the Bradykinin and des‐Arg 9 Bradykinin decreased in adenoma and CRC groups comparing to controls and this could be due to a different activation of peptidase‐mediated catabolic systems.…”
Section: Resultsmentioning
confidence: 99%